85 related articles for article (PubMed ID: 9339367)
1. Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA).
Sjøholt G; Molven A; Løvlie R; Wilcox A; Sikela JM; Steen VM
Genomics; 1997 Oct; 45(1):113-22. PubMed ID: 9339367
[TBL] [Abstract][Full Text] [Related]
2. A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients.
Sjøholt G; Gulbrandsen AK; Løvlie R; Berle JO; Molven A; Steen VM
Mol Psychiatry; 2000 Mar; 5(2):172-80. PubMed ID: 10822345
[TBL] [Abstract][Full Text] [Related]
3. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
Sjøholt G; Ebstein RP; Lie RT; Berle JØ; Mallet J; Deleuze JF; Levinson DF; Laurent C; Mujahed M; Bannoura I; Murad I; Molven A; Steen VM
Mol Psychiatry; 2004 Jun; 9(6):621-9. PubMed ID: 14699425
[TBL] [Abstract][Full Text] [Related]
4. Genomic structure and sequence analysis of a human inositol polyphosphate 1-phosphatase gene (INPP1).
Løvlie R; Gulbrandsen AK; Molven A; Steen VM
Pharmacogenetics; 1999 Aug; 9(4):517-28. PubMed ID: 10780272
[TBL] [Abstract][Full Text] [Related]
5. Characterization of two genes, Impa1 and Impa2 encoding mouse myo-inositol monophosphatases.
Shamir A; Sjøholt G; Ebstein RP; Agam G; Steen VM
Gene; 2001 Jun; 271(2):285-91. PubMed ID: 11418250
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of coding and untranslated regions of rat cortex lithium-sensitive myo-inositol monophosphatase cDNA.
Parthasarathy L; Parthasarathy R; Vadnal R
Gene; 1997 May; 191(1):81-7. PubMed ID: 9210592
[TBL] [Abstract][Full Text] [Related]
7. Human chromosomal localization of a gene for inositol monophosphatase by fluorescence in situ hybridization.
Vadnal R; Heng HH; Parthasarathy L; Parthasarathy R
Neuroreport; 1998 Mar; 9(4):683-5. PubMed ID: 9559938
[TBL] [Abstract][Full Text] [Related]
8. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
Vadnal R; Parthasarathy R
Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
[TBL] [Abstract][Full Text] [Related]
9. Lack of genetic variation in the coding region of the myo-inositol monophosphatase gene in lithium-treated patients with manic depressive illness.
Steen VM; Gulbrandsen AK; Eiken HG; Berle JO
Pharmacogenetics; 1996 Feb; 6(1):113-6. PubMed ID: 8845858
[No Abstract] [Full Text] [Related]
10. Sequence-based identification of inositol monophosphatase-like histidinol-phosphate phosphatases (HisN) in Corynebacterium glutamicum, Actinobacteria, and beyond.
Kulis-Horn RK; Rückert C; Kalinowski J; Persicke M
BMC Microbiol; 2017 Jul; 17(1):161. PubMed ID: 28720084
[TBL] [Abstract][Full Text] [Related]
11. The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness.
Steen VM; Løvlie R; Osher Y; Belmaker RH; Berle JO; Gulbrandsen AK
Pharmacogenetics; 1998 Jun; 8(3):259-68. PubMed ID: 9682271
[TBL] [Abstract][Full Text] [Related]
12. Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis.
Ohnishi T; Murata T; Watanabe A; Hida A; Ohba H; Iwayama Y; Mishima K; Gondo Y; Yoshikawa T
J Biol Chem; 2014 Apr; 289(15):10785-10796. PubMed ID: 24554717
[TBL] [Abstract][Full Text] [Related]
13. A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder.
Yoshikawa T; Turner G; Esterling LE; Sanders AR; Detera-Wadleigh SD
Mol Psychiatry; 1997 Sep; 2(5):393-7. PubMed ID: 9322233
[TBL] [Abstract][Full Text] [Related]
14. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2).
Yoshikawa T; Padigaru M; Karkera JD; Sharma M; Berrettini WH; Esterling LE; Detera-Wadleigh SD
Mol Psychiatry; 2000 Mar; 5(2):165-71. PubMed ID: 10822344
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: molecular and behavioral aspects.
Levi I; Eskira Y; Eisenstein M; Gilon C; Hoffman A; Tal-Gan Y; Fanous J; Bersudsky Y; Belmaker RH; Agam G; Almog O
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1806-15. PubMed ID: 23619164
[TBL] [Abstract][Full Text] [Related]
16. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
17. Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1.
Ohnishi T; Ohba H; Seo KC; Im J; Sato Y; Iwayama Y; Furuichi T; Chung SK; Yoshikawa T
J Biol Chem; 2007 Jan; 282(1):637-46. PubMed ID: 17068342
[TBL] [Abstract][Full Text] [Related]
18. Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
Dimitrova A; Milanova V; Krastev S; Nikolov I; Toncheva D; Owen MJ; Kirov G
Pharmacogenomics J; 2005; 5(1):35-41. PubMed ID: 15505643
[TBL] [Abstract][Full Text] [Related]
19. Lithium modulation of the human inositol monophosphatase 2 (IMPA2) promoter.
Seelan RS; Parthasarathy LK; Parthasarathy RN
Biochem Biophys Res Commun; 2004 Nov; 324(4):1370-8. PubMed ID: 15504365
[TBL] [Abstract][Full Text] [Related]
20. Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs.
Agam G; Shamir A; Shaltiel G; Greenberg ML
Bipolar Disord; 2002; 4 Suppl 1():15-20. PubMed ID: 12479670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
